Letter: COVID-19 Pandemic-The Bystander Effect on Stroke Care in Michigan.
Morbidity and mortality associated with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection are extremely visible1; however, the effect of the COVID-19 pandemic on the management of other pathologies requiring complex interventions and critical care resources—the bystander effect2—is not well described. This is certainly true of stroke patients whose clinical outcomes are a function of early presentation, timely diagnosis, emergent intervention, and critical care management.3-5 With the arrival of COVID-19 cases in the month of March in the hotspot of Michigan, we describe the bystander effect of the COVID-19 pandemic on ischemic and hemorrhagic stroke.
Pandey AS, Daou BJ, Tsai JP, Zaidi SF, Salahuddin H, Gemmete JJ, Oliver MJ, Singer J, Elder TA, Mbabuike N, Adel JG, Gujrati Y, Saleemi MA, Siddiqui FM, Elias AE, Rehman MF, Marin H, Chebl AB, Kole M, Wilseck JM, Kazmierczak CD, Mick JM, Majjhoo AQ, Naravetla BR, Rayes M, Luqman AW, Richards BF, Kelkar P, Burgess R, Thompson BG, Chaudhary N, Mazaris PA, Qahwash O, Razak MA, Jumaa MA; Michigan Stroke Treatment Improvement Collaborative (MISTIC). Letter: COVID-19 Pandemic-The Bystander Effect on Stroke Care in Michigan. Neurosurgery. 2020 Sep 1;87(3):E397-E399. doi: 10.1093/neuros/nyaa252. PMID: 32496518; PMCID: PMC7313842.